Burkholderia pseudomallei is the etiological agent of melioidosis, a potentially fatal disease occurring in man and animals. The aim of this study was to investigate the pathophysiological course of experimental melioidosis, and to identify the target organs, in an animal model. For this purpose SWISS mice were infected intraperitoneally with the virulent strain B. pseudomallei 6068. The bacterial load of various organs was quantified daily by bacteriological analysis and by an enzyme-linked immunosorbent assay (ELISA) based on a monoclonal antibody specific to B. pseudomallei exopolysaccharide (EPS). Electron microscopic investigation of the spleen was performed to locate the bacteria at the cellular level. In this model of acute melioidosis, B. pseudomallei had a marked organ tropism for liver and spleen, and showed evidence of in vivo growth with a bacterial burden of 1.6U10 9 colony forming units (CFU) per gram of spleen 5 days after infection with 200 CFU. The highest bacterial loads were detected in the spleen at all time points, in a range from 2U10 6 to 2U10 9 CFU g 31 . They were still 50^80 times greater than the load of the liver at the time of peak burden. Other investigated organs such as lungs, kidneys, and bone marrow were 10 2^1 0 4 -fold less infected than the spleen, with loads ranging from 3U10 2 to 3U10 6 CFU g 31 . The heart and the brain were sites of a delayed infection, with counts in a range from 10 3 to 10 7 times lower than bacterial counts in the spleen. The EPS-specific ELISA proved to be highly sensitive, particularly at the level of those tissues in which colony counting on agar revealed low contamination. In the blood, EPS was detected at concentrations corresponding to bacterial loads ranging from 8U10 3 to 6U10 4 CFU ml 31 . Electron microscopic examination of the spleen revealed figures of phagocytosis, and the presence of large numbers of intact bacteria, which occurred either as single cells or densely packed into vacuoles. Sparse figures suggesting bacterial replication were also observed. In addition, some bacteria could be seen in vacuoles that seemed to have lost their membrane. These observations provide a basis for further investigations on the pathogenesis of the disease. ß
Introduction
Burkholderia pseudomallei is a Gram-negative saprophytic soil bacterium which is the etiological agent of melioidosis, a potentially fatal disease occurring in man and animals. This infectious disease is endemic in South-East Asia and Northern Australia, and in intertropical zones of Africa, the Indian subcontinent and South-America [1] . The occurrence of sporadic cases in Northern America and Europe in the 70s led to intense investigation in the ¢elds of epidemiology, diagnosis and therapeutics. In endemic zones, infection is thought to occur by inhalation of infectious particles or by the contact of wounds or damaged skin surface with contaminated soil or water [1, 2] .
The disease of humans shows diverse clinical pictures, ranging from asymptomatic state manifested by seroconversion only, localized infection such as pneumonia, to acute fatal septicemia with a case fatality rate over 90% if untreated [1, 2] . After cessation of antibiotic therapy re-lapse is common [3] , and in many cases relapse results from reactivation of a persistent endogenous focus [4] . This infection may break out after long periods of latency [5] . B. pseudomallei can survive in a dormant stage [2] for months and years until reactivated, in such adverse environments as soil [2, 6] , water [2, 7, 8] , or the intracellular compartment of infected animals or humans [5] . Its adaptability to acidic environments [9] may explain its putative capability to survive in the phagolysosome of macrophages [9, 10] . B. pseudomallei can invade various epithelial cell lines [11^13] , and is able to survive and grow intracellularly within phagocytes like polymorphonuclear leukocytes (PMNLs) and monocytes [10, 12, 14, 15] , even though this point is the subject of controversy [16^19] .
The persistence of viable B. pseudomallei cells within abscesses in the liver, spleen or lungs of melioidosis patients is believed to underline the high rate of relapse observed upon cessation of antimicrobial therapy or when defense mechanisms are impaired [2] .
The successful treatment of melioidosis patients is di¤-cult because B. pseudomallei develops resistance to a variety of antibiotics [1, 20] , and even with appropriate antibiotic therapy the mortality in such patients is 40% or higher [3] . In addition, when the infection turns into the latent stage, drugs should be less e¤cient because bacteria are in the dormant conditions [2] . Furthermore, there is currently no licensed vaccine available for immunoprophylaxis of melioidosis, although an experimental vaccine that is a £agellin^polysaccharide glycoconjugate seems to be a reasonable candidate [21^23] .
Melioidosis a¡ects a wide range of animal species, from mammals to birds and ¢sh, with varying severity and clinical manifestations [1, 24] . In the years 1940^1950, various experimental studies showed that many laboratory animal species, such as hamster, guinea pig, rabbit, monkey, rat and mouse, are sensitive to B. pseudomallei infection [252 7] . De Shazer et al. also developed an infant diabetic rat model of experimental melioidosis [28] . Although less sensitive to this infection than hamster or guinea pig, the mouse proved to be an interesting model [26,29^32] . Furthermore, inbred mouse strains develop a host-dependent infection [33, 34] , thus providing a good animal model for both the acute and chronic forms of melioidosis [34, 35] . Tinelli et al. and Martin et al. developed a SWISS mouse model of experimental melioidosis with strain B. pseudomallei 6068. This model has proven to be appropriate for studying the pathogenic e¡ects of B. pseudomallei after intraperitoneal (i.p.) or intravenous infection [29^31] .
The aim of the current study was ¢rstly to assess, on the basis of bacteriological and electron microscopic (EM) methods, the initial stages of the infection in terms of organ tropism, bacterial load in the tissues, and location of B. pseudomallei at the cellular level. The second objective was to evaluate an enzyme-linked immunosorbent assay (ELISA) for improving and facilitating such pathophysiological investigations on melioidosis.
Materials and methods

Biosafety requirements
Bacterial cultures, experimental infections, sampling of organs and colony forming units (CFU) counting on agar were performed in a biosafety level 3 laboratory (BSL3). Samples processed for either ELISA or EM were inactivated as described below before use.
Bacterial strain and culture conditions
The strain B. pseudomallei 6068 was initially isolated in 1952 from a patient with melioidosis in the Institut Pasteur of Sa| «gon [36] . This strain was previously either attenuated by repeated subcultures on glycerinated agar (6068 AG), or rendered virulent by four consecutive passages in mice (6068 VIR) [30] . This strain was stored at 380³C in broth supplemented with 30% glycerol until use. For experimental infection we used the virulent strain 6068 VIR. An overnight shaken bacterial culture in Brain Heart Infusion broth at 37³C (Difco Laboratories) was centrifuged, washed twice, and serially diluted in sterile saline at physiological pH to the desired concentration. The infective dose for an acute infection was based on previous experimentation [37] .
Mice and experimental infection
This study was approved by the C.R.S.S.A. Emile Pardë Animal Care Committee (no. 3/99). SWISS female mice were purchased from Centre d'Elevage R. Janvier, Le Genest St. Isle, France. Animals were fed U.A.R. chow (Epinay-sur-Orge, France), and water ad libitum, and were used at 8^9 weeks of age. The ¢rst experimental group (group A) consisted of 10 mice, infected via the i.p. route with 200 CFU, and was used for survival rate analysis only. The second experimental group (group B) consisted of 15 mice, infected i.p. with 200 CFU of the same bacterial suspension. The sampling of organs from killed mice of group B started 2 days after infection. One non-infected mouse served as a control.
Sampling of organs
The bacterial load of organs was determined at days 2, 3, 4, 5, and 7 after challenge.
The blood was obtained from the orbital sinus of mice under light ether anesthesia. Mice were then killed by cervical dislocation, and peritoneal £uid was obtained by lavaging the abdominal cavity with sterile saline. The organs and other biological samples collected were the liver, spleen, lungs, kidneys, brain, heart, and the femoral bone marrow. After aseptic removal of the organs all solid samples were aseptically divided, and a fragment was weighed and processed for CFU determination by counting on agar as described below, and exopolysaccharide (EPS) quanti¢cation by ELISA. At each time point, a small piece from the spleen was also processed for EM.
CFU counting on agar
Organ fragments were homogenized in 3 ml of sterile saline in a tissue homogenizer (Potter cell grinder), and 1-ml samples of 10-fold serial dilutions were plated onto Plate-count-agar (Merck, D-64293 Darmstadt, Germany) and incubated at 37³C for 72 h. The bacterial load was expressed as the number of CFU per gram of organ or per milliliter of sample.
Quanti¢cation of B. pseudomallei EPS by ELISA
Detection of B. pseudomallei EPS was performed as previously described [38] . The monoclonal antibody (mAb) PS6F6 has shown to be speci¢c for EPS of B. mallei and B. pseudomallei strains by application of Western blot techniques (data not shown). Typically EPS is demonstrated as a di¡use signal clearly ranging in the molecular mass over 200 kDa [39] . Brie£y, to 100 Wl of the homogenates or aseptically drawn blood, 100 Wl of EPS extraction bu¡er (Chlamydia specimen extraction bu¡er, Abbott laboratories, D-65205 Wiesbaden, Germany) was added, and heated at 96³C for 30 min. The suspension was then centrifuged at 1000Ug for 10 min, and the supernatant was used for further ELISA steps. This means that the supernatant contained EPS and lipopolysaccharide (LPS); but it can be supposed that it also contained other soluble fractions of the bacterial cell.
Microtitration plates were coated with mAb PS6F6 speci¢c to B. pseudomallei EPS. 100-Wl aliquots of extracts, diluted 2-fold with phosphate-bu¡ered saline (PBS), were added into the wells, and the plates were incubated for 1 h at 37³C. After four washing steps with PBS, biotinylated mAb PS6F6 was added, and the plates were incubated for another 1 h at 37³C. After four washing steps with PBS, 100 Wl streptavidin-POD conjugate was added, and the plates were incubated for 1 h at 37³C. After four additional washing steps, TMB (3,3P,5,5P-tetramethylbenzidine) was added as substrate and incubated at 20³C for 15 min. The reaction was then stopped with 25 Wl of 2.5 M H 2 SO 4 , and the absorbance was read at 450 nm. A positive control was performed with an EPS extract from B. pseudomallei strain ATCC 15682. The cut-o¡ of the ELISA was ¢xed to an optical density (OD) of 0.2.
A washed suspension of B. pseudomallei 6068 containing 5U10 8 CFU per ml was inactivated in EPS extraction bu¡er, as described above. It was then serially diluted in saline to obtain graded concentrations of EPS, to correlate OD 450 readings to CFU. Values exceeding 1.7U10 6 CFU ml 31 or below 5.5U10 2 were out of range of the spectrophotometer. A standard curve was generated under PRISM software (GraphPad PRISM1, 10855, San Diego, CA 92121, USA) ( Fig. 1 ).
EM study
Small 1-mm 3 cubes of spleen were ¢xed by immersion into a 3% glutaraldehyde solution, and kept on ice for 3 h. The fragments were then post-¢xed in a 2% osmium tetroxide solution for 1 h at room temperature. They were then dehydrated in a graded series of 50%, 70%, 95% and 100% ethanol, and embedded in LR White resin. After staining for 1 min in 2% uranyl acetate and 1 min in lead acetate, ultrathin 80-nm sections were examined under a JEOL 1010 transmission electron microscope (Japan Electron Optics Laboratory Co. Ltd., Tokyo, Japan). 
Results
Course of acute infection
The course of acute B. pseudomallei infection in SWISS mice from group A, represented by mice survival rate following i.p. challenge, is illustrated in Fig. 2 . Deaths started 4 days after challenge with 200 CFU of strain 6068, and nine of the 10 mice died within 6 days (Fig. 2) . In group B, deaths started 3 days after inoculation, and most of the mice progressively developed clinical signs of illness. Eight animals died between day 3 and day 7, and no material was collected from these mice. At each time point, isolation of B. pseudomallei was done from organs of the surviving mice only.
Organ tropism of B. pseudomallei, and bacterial load of the organs
On the next ¢gure is evidenced a marked organ tropism of the bacteria for the spleen and the liver (Fig. 3) . The highest bacterial loads were observed in the spleen at each time point after infection, with counts in a range from 2U10 6 to 2U10 9 CFU per gram of tissue. At the peak burden, which occurred in all organs from mouse no. 15 at d+4 post-infection and mouse no. 7 at d+5, the spleen load was still 50^80 times greater than the load of the liver. Bacteria were detected in all organs at the time points of peak spleen load (Fig. 3) . Furthermore, bacteria could be recovered from brain and heart only at these time points, at a magnitude of 2^5U10 2 , or 7U10 3^3 U10
5
CFU per gram of organ, respectively (Fig. 3) . Correlatively, no bacteria were detected in the organs, except the liver, at the nadir of spleen load, which occurred in mouse no. 3 at d+3 post-infection at a magnitude of 69 CFU g 31 (Fig. 3) . Bacterial counts in the lungs, kidneys, and bone marrow were in an average range of 3U10 2^3 U10 6 CFU g 31 , that is to say 10 2^1 0 4 -fold less than those observed in the spleen ( Table 1) . As mentioned above, the heart and the brain were to a lesser extent the sites of a delayed infection, with counts in a range from 10 3 to 10 7 times lower than bacterial counts in the spleen (Fig. 3) .
We could not document the CFU content of organs beyond day 7 after infection because of the progressive death of all mice.
Comparison between ELISA detection of bacterial
EPS and CFU counting on agar, for determining the bacterial load of organs investigated B. pseudomallei EPS was detected in the blood, with OD ranging from 0.4 to 1.3, corresponding to bacterial concentrations ranging from 7.4U10 3 to 5.5U10 4 CFU ml 31 . Nevertheless, blood could not be collected from mouse no. 15 at d+4 and mouse no. 7 at d+5 post-infection, which both developed an acute sepsis (Fig. 4) .
The other results are compared in Table 1 . They show that, at most time points, the determinations of bacterial concentrations were with a few exceptions almost equiva- lent by both methods, in the liver, spleen, bone marrow and peritoneal exudate. Furthermore, the ELISA con¢rmed that at the time point of lowest spleen load, in mouse no. 3 at d+3, all organs were sterile, except the lungs. Nevertheless, the variations between CFU calculated using ELISA quanti¢cation of EPS (CFU OD ) and CFU determined by colony counting on agar (CFU B ) were obvious in brain samples. Colony counting corresponded to bacterial loads at a magnitude of 10 CFU g 31 2 days after infection, to 100 CFU after 4^5 days; whereas ELISA readings corresponded to 5U10 5 and 1U10 6 CFU g 31 , respectively. Furthermore, ELISA detection seemed to be more sensitive than colony counting in the lungs, the kidneys and the heart. This was especially the case with organs from mouse no. 10 from which no bacteria could be grown on agar, whereas a bacterial load of more than 3U10 6 CFU g 31 was determined by the ELISA (Table  1) . More generally, ELISA detection proved to be more sensitive when low numbers 6 10 3 CFU g 31 were counted on agar (Table 1) .
In vivo bacterial multiplication and clinical signs of illness
In terms of bacterial growth, all organs displayed increasing loads after 4^5 days, reaching 1.6U10
9 CFU per gram of spleen and 2U10 7 or 1.5U10 7 CFU in the liver or peritoneal exudate, respectively. Bacterial loads in other organs are shown for comparison with growth in the spleen (Fig. 5) .
Clinical observations showed that signs of illness occurred as soon as 3 days after infection with 200 CFU, and mortality started at the same time. Splenic and hepatic abscesses were macroscopically visible at the fourth day, with a bacterial burden of approximately 1U10 8^1 U10 9 or 1U10 5^1 U10 7 CFU g 31 , respectively. Two mice showed clinical signs of acute sepsis at this time. Nevertheless, a mouse that was asymptomatic and developed no clinical signs of illness and no macroscopically visible abscesses, mouse no. 2 at d+2 post-infection, showed a bacterial burden in the spleen of 2U10 7 CFU g 31 . Correlatively, another mouse, no. 3 at d+3, with a splenic bacterial load of 69 CFU g 31 only and no bacteria detected in other organs, except 8U10 3 CFU in the liver, showed marked signs of illness.
EM examination of the spleen
EM examination of the spleen revealed images evoking phagocytosis (Fig. 6A) . The presence of large numbers of intact bacteria was evidenced, which occurred either as single cells in a membrane-bound vacuole (Fig. 6B) , or densely packed into vacuoles (Fig. 6C) . Packed bacteria seemed to be included in an electron-dense (E.D.) substance (Fig. 6C,D) . Sparse ¢gures that suggest bacterial replication were also observed (Fig. 6D ). In addition, some bacteria could be seen in vacuoles that seemed to have lost their membrane (Fig. 7E-b) , when compared to membrane-bound vacuoles (Fig. 7E-a) . Nevertheless, an image evoking a bacterium undergoing morphologic changes, suggesting lysis of the bacterial cell, was also observed (Fig. 7F) .
Discussion
The course of B. pseudomallei infection in SWISS outbred mice observed in our study is in accordance with other observations in BALB/c inbred mice [32, 34, 35] . In a comparative study between C57BL/6 and BALB/c mice infected with B. pseudomallei via the intravenous route, Hoppe et al. showed that, in both stains of mice, the course of infection was highly dependent on the infective dose. Infection resulted in deaths ranging from a few days to several weeks after challenge. Bacterial counts in the spleen of C57BL/6 mice were decreased 12 h after infection, whereas BALB/c mice did not clear the bacteria and succumbed to infection [35] . This work also pointed out a marked organ tropism of B. pseudomallei for the spleen and the liver, with the highest loads in the spleen. Nevertheless, in contrast to our observations, relatively few bacteria were detected in the lungs and kidneys of the sensitive BALB/c mice. No bacteria were detected in the lungs and kidneys of the resistant C57BL/6 mice at any time point. Furthermore, bacteria were not detectable in the blood from both strains, even after challenge with 5U10 3 CFU [35] . In our experiment, due to lack of material, detection of bacteria in the blood was made by ELISA only. Nevertheless, the OD values obtained revealed a septicemia ranging from 7.4U10 3 CFU to 5.5U10 4 CFU per ml of blood, between days 2 and 7 after i.p. infection. Other investigators showed that a rapidly increasing bacterial load within the blood of the sensitive BALB/c mice occurred after infection, reaching more than 1U10 4 CFU ml 31 at 72 h, contrasting with the absence of viable bacteria in the blood of C57BL/6 mice at 96 h. They concluded that a bacteremia dictates the fatal outcome consistently observed in BALB/c mice [34] .
In terms of bacterial growth, our results obtained with the SWISS mice model are comparable with the results of Leakey et al. The authors mentioned that both the spleen and liver of BALB/c mice displayed steadily increasing bacterial loads in the 72 h following infection, reaching 10 8 CFU ml 31 and 10 7 CFU ml 31 , respectively [34] . We observed that all organs displayed increasing loads 4^5 days following infection, reaching 1.6U10 9 CFU per gram of tissue in the spleen, and 2U10 7 CFU in the liver. In a model of i.p. infection, Santanirand et al. demonstrated that the outbred TO mice were approximately 100-fold more resistant to acute B. pseudomallei infection than BALB/c mice, and that sublethaly infected TO mice showed little evidence of bacterial growth. They exhibited a progressive decline in viable B. pseudomallei in the target organs, and 99% of the bacteria were cleared from the spleen and liver within 4 days after infection. The majority of animals progressed to apparent sterilization of these organs by 28 days after infection, and this was associated with progressive splenomegaly and the rapid development of granulomas [32] .
Clinical manifestations of melioidosis in the SWISS mice were evident 3 days after infection, with splenic and hepatic abscesses macroscopically visible at the fourth day, and a high bacterial burden in these organs. Some mice showed clinical signs of acute sepsis at this time. Nevertheless, a mouse that was asymptomatic and developed no clinical signs of illness and no macroscopically visible abscesses showed a bacterial burden in the spleen of 2U10 7 CFU per gram of tissue. These observations are similar to observations by Santanirand et al., who showed that one single mouse in their experiment, which had shown no clinical signs of illness, and negligible numbers of bacteria in other organs, exhibited multiple abscesses in the spleen, yielding more than 10 8 CFU per organ [32] . This suggests that focal growth can occur without overt signs of infection. Correlatively, a SWISS mouse from our study, no. 3 at d+3, with a very low splenic bacterial load of 69 CFU g 31 , and no bacteria detected in other organs, but 8U10
3 CFU g 31 in the liver, showed marked signs of illness. Nevertheless, the highest bacterial loads were in the spleen of SWISS mice at all other time points after infection. Even at the time of peak burden, in mouse no. 15 at d+4 post-infection and in mouse no. 7 at d+5, the spleen load was 50^80 times greater than the load of liver. This supports the hypothesis of Dannenberg that the liver of the mouse seems to possess greater native resistance to melioidosis than the spleen [26] . Our EM observations of spleen from infected SWISS mice revealed images of phagocytosis, and the presence of large numbers of intact bacteria, either as single cells or densely packed, into membrane-bound vacuoles.
Nevertheless, some bacteria could be seen in vacuoles that seemed to have lost their membrane. Conversely, an image evoking a bacterium undergoing morphologic changes was also observed, which suggested bacterial lysis. A few ¢gures of bacterial replication, possibly into PMN cells, were also observed, though the question of whether this multiplication occurred before or after ingestion by the phagocyte cannot be answered.
All these observations are in accordance with EM investigations of the spleen from infected BALB/c mice, which clearly demonstrated intracellular replication of B. pseudomallei within membrane-bound phagosomes. They consistently showed the presence of large numbers of intact bacterial cells, which in many cases appeared densely packed within a membrane [35] . Furthermore EM of the liver also provided evidence that B. pseudomallei-containing phagosomes in hepatocytes fuse with lysosomes, leading to degradation of the bacteria [35] . In a murine model of acute respiratory melioidosis, histopathologic investigations by Dannenberg et al. showed that in the lungs, the bacteria were scarce and almost always located within mononuclears. At lower infecting doses, scattered bacteria were seen in both mononuclear cells and PMN, and 4 days after infection most of the lesions contained extracellular as well as intracellular bacteria [26] . In a goat model of experimental melioidosis, Narita observed that the in¢ltrating cells found in the lesions were mainly macrophages and ¢broblasts, and that numerous bacteria were located in the cytoplasm of the macrophages. Most of the bacilli were surrounded by an E.D. substance, and a clear halo existed between this E.D. substance and the bacillary wall [40] . These pictures were also observed in the spleen of SWISS mice infected with B. pseudomallei as described above (Fig.  6C,D) . The halo suggests the presence of a bacterial capsule, as previously described in vivo by Popov et al., which was supposed to confer to the bacteria resistance against the destructive contents of phagolysosomes [41] .
Indeed, several features of melioidosis suggest that B. pseudomallei may survive in an intracellular niche : (1) observations of structurally intact bacteria within macrophages in experimental melioidosis ( [26, 35, 40] , this study), (2) in vitro evidence of intracellular survival of B. pseudomallei [10^12, 14, 15] . Investigators have also reported in vitro multiplication of B. pseudomallei in various professional phagocytes, human PMNLs and mononuclear leukocytes [10, 16] , or alveolar macrophages [12] . In the cultured phagocytic cell lines, RAW 264, J774, HeLa, U937 and mouse peritoneal macrophages, Harley et al. demonstrated that after phagocytosis of B. pseudomallei, the bacteria were seen in vacuoles [42] . The organisms appeared initially in phagosomes with intact membranes, and there was no evidence for fusion of phagosomes and lysosomes. After longer incubations the phagosomal membranes partly or completely disappeared, so that bacilli escaped into the cytoplasm. Multiplication may also have occurred, because dividing bacteria were seen in the phagosomes [15, 42] . In a further work these authors showed that B. pseudomallei invade cultured cell lines, macrophagelike, epithelial or ¢broblasts, and that uptake was followed by the intracellular multiplication of the bacteria. Loss of the phagocyte membrane around the internalized bacillus was observed, allowing the organism to come into direct contact with the host cytoplasm [11] . Although evidence is less obvious, it seems very likely to some authors that intracellular replication occurs in vivo [43] . This assumption is stressed by the presence of type III secretion mechanisms in B. pseudomallei, which play a major role in the interaction between the pathogen and the host cells [44] .
Although intracellular persistence and multiplication of B. pseudomallei is documented [10^12, 14, 42] , there are con£icting reports concerning its susceptibility to the microbicidal activity of professional phagocytes. Egan et al. showed that despite opsonophagocytosis of B. pseudomallei by human PMNL, and the production of an oxidative response, no signi¢cant bacterial killing was observed [14] . Jones also demonstrated that B. pseudomallei has the capacity to survive intracellularly in professional phagocytic cells including rat alveolar macrophages, human PMNL, or U937 cells. EM studies con¢rmed the presence of intracellular bacteria within membrane-bound vacuoles in PMN [12] . All these ¢ndings are in accordance with our EM observations evoking intact bacteria in vacuoles after phagocytosis.
Nevertheless, Razak et al. observed that although untreated B. pseudomallei are relatively resistant to phagocytosis, however, once opsonized by heat-labile serum components they are avidly ingested and killed by human PMNL in vitro. Moreover, EM observation suggested phagosome^lysosome fusion and bacterial morphologic changes occurring within 1 h after the organism was ingested. Consequently, the authors suggest that the occasional chronic nature of melioidosis cannot be explained simply by the putative ability of B. pseudomallei to survive within leukocytes [16] . Furthermore, Miyagi et al. demonstrated that if B. pseudomallei multiplied well in unstimulated murine macrophage cell line J774.1, activation with IFN-Q induced a strong RNI-and ROI-mediated bactericidal activity [45] . According to other investigators, the di¡erences in the bactericidal activity of peritoneal macrophages and PMNL from di¡erent animal species, chicken, sheep, swine and rabbit, should correlate with the level of their acid phosphatase and glycolytic activity [18] . Furthermore, Ulett et al. demonstrated that although enriched murine peritoneal exudate cells (PEC) alone are unable to e¡ectively kill B. pseudomallei, e¤cient antimicrobial activity of PEC towards B. pseudomallei depends on interactions between macrophages and lymphocytes [19] . Correlatively, Ho et al. showed that antibodies to the LPS Opolysaccharides of B. pseudomallei are protective by promoting phagocytic killing, and that sera from melioidosis patients also mediated phagocytic killing by PMNL [17] .
In other respects, our work brought evidence that an ELISA based on a mAb speci¢c to B. pseudomallei EPS, exhibited a greater sensitivity than colony counting on agar, for the determination of bacterial load of organs. This method proved to be an accurate and sensitive tool for investigations on melioidosis. However, we are well aware that a correlation of viable cell counts and EPS detection harbors various shortcomings. The EPS detected could also be part of non-viable bacteria, resulting in a higher cell count than by CFU counting on agar. It may also be possible that EPS biosynthesis is a¡ected by the environment the bacterium ¢nds itself in. This may account for the variation seen in the bacterial number calculated by viable counts and by ELISA, as seen in Table 1 . These ¢rst results indicate that it is necessary in the future to use a larger number of animals so as the experiment can be performed in triplicate to give con¢dence to the observations made in this study. Also, the in£uence of the genetic background of the SWISS mouse strain on the obtained data has to be elucidated in the future.
Our observations in this study, based on bacteriological and EM methods, described the initial stages of the infection in terms of organ tropism, bacterial load of the tissues and location of B. pseudomallei at the cellular level. They provide a basis for further investigations on the pathogenesis of melioidosis.
